CBR1 and acute lymphoblastic leukemia: The target genes of the described miRNAs are involved in the metabolic pathways of drugs used in ALL chemotherapy, including NFKBIE and CBR1 in daunorubicin metabolism and MTHFR, MTR and SLC46A1 in MTX metabolism [33].